FDA Approves Risankizumab for Ulcerative Colitis ...Middle East

The approval is the fourth indication for the anti–interleukin 23 monoclonal antibody after approval for Crohn's disease, psoriatic arthritis, and plaque psoriasis. Medscape Medical News

Hence then, the article about fda approves risankizumab for ulcerative colitis was published today ( Wednesday 19/06/2024 - 07:41 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Risankizumab for Ulcerative Colitis )

Also on site :

• RECYCLEXPERT FZE Strengthens Leadership in Data Destruction UAE and GCC with Certified Secure ITAD Services
• Zelensky’s inner circle accused of war profiteering
• Rolling Stones Mick Jagger, Keith Richards, and Ronnie Wood Have the Time of Their Life on the Red Carpet